DepiMedia™

DepiMedia™

Zimbabwe to launch long-acting injectable HIV drug

Early next year, Zimbabwe is set to commence its initial rollout of a long-acting injectable HIV prevention drug, with approximately 46,500 individuals slated to begin treatment. This is the first injectable drug for pre-exposure prophylaxis of HIV (PrEP), with a…